|
1
|
Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot‐Corbel E, Bjerke M, Blanc‐Quintin M, Boada M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dumurgier J, Dufour‐Rainfray D, Engelborghs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau‐Rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Körtvelyessy P, Kulczynska‐Przybik A, Laplanche J, Lewczuk P, Li Q, Lleó A, Malaplate C, Marquié M, Masters CL, Mroczko B, Nogueira L, Orellana A, Otto M, Oudart J, Paquet C, Paoletti FP, Parnetti L, Perret‐Liaudet A, Peoc'h K, Poesen K, Puig‐Pijoan A, Quadrio I, Quillard‐Muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suárez‐Calvet M, Tsolaki M, Tumani H, Udeh‐Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimers Dement 2022; 18:1868-1879. [PMID: 34936194 PMCID: PMC9787404 DOI: 10.1002/alz.12545] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Revised: 10/11/2021] [Accepted: 10/25/2021] [Indexed: 01/28/2023]
Abstract
INTRODUCTION The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same biochemical profile, interpretation and reporting of results may differ, which can lead to misunderstandings and raises questions about the commutability of tests. METHODS We obtained a description of (pre-)analytical protocols and sample reports from 40 centers worldwide. A consensus approach allowed us to propose harmonized comments corresponding to the different CSF biomarker profiles observed in patients. RESULTS The (pre-)analytical procedures were similar between centers. There was considerable heterogeneity in cutoff definitions and report comments. We therefore identified and selected by consensus the most accurate and informative comments regarding the interpretation of CSF biomarkers in the context of AD diagnosis. DISCUSSION This is the first time that harmonized reports are proposed across worldwide specialized laboratories involved in the biochemical diagnosis of AD.
Collapse
Affiliation(s)
- Constance Delaby
- LBPC‐PPCUniv MontpellierCHU MontpellierINSERMMontpellierFrance,Hospital de la Santa Creu i Sant Pau ‐ Biomedical Research Institute Sant Pau ‐ Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Charlotte E. Teunissen
- Neurochemistry LabDepartment of Clinical ChemistryAmsterdam NeuroscienceAmsterdam UMCVrije Universiteit AmsterdamAmsterdamNetherlands
| | - Kaj Blennow
- Institute of Neuroscience and PhysiologyThe Sahlgrenska Academy at the University of GothenburgGothenburgSweden
| | - Daniel Alcolea
- Hospital de la Santa Creu i Sant Pau ‐ Biomedical Research Institute Sant Pau ‐ Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Ivan Arisi
- European Brain Research Institute (EBRI) “Rita Levi‐Montalcini”RomaItaly
| | - Elodie Bouaziz Amar
- Université de ParisCognitive Neurology CenterGHU APHP Nord Lariboisière Fernand‐Widal HospitalParisFrance
| | | | | | - Giovanni Bellomo
- Lab of Clinical NeurochemistrySection of NeurologyDept. of Medicine and SurgeryUniversity of PerugiaPerugiaItaly
| | | | - Maria Bjerke
- Vrije Universiteit BrusselCenter for Neurosciences and Department of Clinical BiologyClinical Neurochemistry LaboratoryUniversitair Ziekenhuis BrusselBrusselsBelgium,Department of Biomedical Sciences, Institute Born‐BungeUniversity of AntwerpAntwerpBelgium
| | | | - Mercè Boada
- Research Center and Memory ClinicFundació ACEInstitut Català de Neurociències Aplicades and Universitat Internacional de Catalunya (UIC)BarcelonaSpain,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)Instituto de Salud Carlos IIIMadridSpain
| | - Olivier Bousiges
- Laboratoire de Biochimie et Biologie Moléculaire, et CNRSICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg)Team IMISHôpitaux Universitaires de StrasbourgStrasbourgFrance
| | - Miles D Chapman
- Department of NeuroimmunologyNational Hospital for Neurology and Neurosurgery, UCL Queen SquareLondonUK
| | - Mari L. DeMarco
- Department of Pathology and Laboratory MedicineSt. Paul's Hospital, Providence Health Care, Vancouver, Canada & Department of Pathology & Laboratory MedicineUniversity of British ColumbiaVancouverCanada
| | - Mara D'Onofrio
- European Brain Research Institute (EBRI) “Rita Levi‐Montalcini”RomaItaly
| | - Julien Dumurgier
- Université de ParisCognitive Neurology CenterGHU APHP Nord Lariboisière Fernand‐Widal HospitalParisFrance
| | | | - Sebastiaan Engelborghs
- Department of Biomedical Sciences, Institute Born‐BungeUniversity of AntwerpAntwerpBelgium,Vrije Universiteit BrusselUniversitair Ziekenhuis BrusselCenter for Neurosciences and Department of NeurologyBrusselsBelgium
| | - Hermann Esselmann
- Department of Psychiatry and PsychotherapyUniversity Medical Center Goettingen (UMGGoettingenGermany
| | - Anne Fogli
- CHU Clermont‐FerrandClermont‐FerrandFrance
| | - Audrey Gabelle
- LBPC‐PPCUniv MontpellierCHU MontpellierINSERMMontpellierFrance
| | | | | | | | - Oriol Grau‐Rivera
- Barcelonaβeta Brain Research Center (BBRC)Pasqual Maragall FoundationBarcelonaSpain,Servei de NeurologiaHospital del MarUnitat de deteriorament cognitiu i transtorns del movimentBarcelonaSpain,IMIM (Hospital del Mar Medical Research Institute)BarcelonaSpain,Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES)MadridSpain
| | - Melanie Hart
- Department of NeuroimmunologyNational Hospital for Neurology and Neurosurgery, UCL Queen SquareLondonUK
| | - Takeshi Ikeuchi
- Dept. of Molecular GeneticsCenter for BioresourcesBrain Research InstituteNiigata UniversityNiigataJapan
| | | | - Kensaku Kasuga
- Dept. of Molecular GeneticsCenter for BioresourcesBrain Research InstituteNiigata UniversityNiigataJapan
| | - Ashvini Keshavan
- Dementia Research CentreUCL Queen Square Institute of NeurologyLondonUK
| | | | - Peter Körtvelyessy
- Freie Universität Berlin and Humboldt‐Universität zu BerlinDepartment of NeurologyGerman Center for Neurodegenerative Diseases, Magdeburg, Germany and Charité‐Universitäts medizin BerlinBerlinGermany
| | | | - Jean‐Louis Laplanche
- Université de ParisCognitive Neurology CenterGHU APHP Nord Lariboisière Fernand‐Widal HospitalParisFrance
| | - Piotr Lewczuk
- Department of Neurodegeneration DiagnosticsMedical University of BialystokBialystokPoland,Lab for Clinical Neurochemistry and Neurochemical Dementia DiagnosticsUniversitätsklinikum Erlangen and Friedrich‐Alexander Universität Erlangen‐NürnbergErlangenGermany
| | - Qiao‐Xin Li
- Florey Institute and The University of MelbourneMelbourneVictoriaAustralia
| | - Alberto Lleó
- Hospital de la Santa Creu i Sant Pau ‐ Biomedical Research Institute Sant Pau ‐ Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Catherine Malaplate
- CHRU de NancyLaboratoire de BiochimieBiologie Moléculaire et Nutrition/ Université de LorraineNancyFrance
| | - Marta Marquié
- Research Center and Memory ClinicFundació ACEInstitut Català de Neurociències Aplicades and Universitat Internacional de Catalunya (UIC)BarcelonaSpain,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)Instituto de Salud Carlos IIIMadridSpain
| | - Colin L. Masters
- Florey Institute and The University of MelbourneMelbourneVictoriaAustralia
| | - Barbara Mroczko
- Department of Neurodegeneration DiagnosticsMedical University of BialystokBialystokPoland
| | - Léonor Nogueira
- Laboratoire de Biologie Cellulaire et CytologieCHU PURPANToulouseFrance
| | - Adelina Orellana
- Research Center and Memory ClinicFundació ACEInstitut Català de Neurociències Aplicades and Universitat Internacional de Catalunya (UIC)BarcelonaSpain,Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)Instituto de Salud Carlos IIIMadridSpain
| | - Markus Otto
- Department of Neurology and CSF LaboratoryUniversity of UlmUlmGermany
| | | | - Claire Paquet
- Université de ParisCognitive Neurology CenterGHU APHP Nord Lariboisière Fernand‐Widal HospitalParisFrance
| | - Federico Paolini Paoletti
- Lab of Clinical NeurochemistrySection of NeurologyDept. of Medicine and SurgeryUniversity of PerugiaPerugiaItaly
| | - Lucilla Parnetti
- Lab of Clinical NeurochemistrySection of NeurologyDept. of Medicine and SurgeryUniversity of PerugiaPerugiaItaly
| | - Armand Perret‐Liaudet
- Lyon Neuroscience Research Center BIORAN Team ‐ CNRS UMR 5292INSERM U1028Lyon University HospitalLyonFrance
| | - Katell Peoc'h
- Université de Paris GHU APHP Nord Beaujon HospitalParisFrance
| | - Koen Poesen
- Laboratory for Molecular Neurobiomarker Research (LaMoN)Department of NeurosciencesKU LeuvenLeuven Brain InstituteLeuvenBelgium
| | - Albert Puig‐Pijoan
- Servei de NeurologiaHospital del MarUnitat de deteriorament cognitiu i transtorns del movimentBarcelonaSpain,IMIM (Hospital del Mar Medical Research Institute)BarcelonaSpain
| | - Isabelle Quadrio
- Lyon Neuroscience Research Center BIORAN Team ‐ CNRS UMR 5292INSERM U1028Lyon University HospitalLyonFrance
| | - Muriel Quillard‐Muraine
- UNIROUENRouen University HospitalDepartment of Clinical biologyBiochemistry laboratoryNormandie UnivRouenFrance
| | | | - Susanna Schraen
- InsermCHU LilleU1172‐LilNCogLICENDLabEx DISTALZUniversité de LilleLilleFrance
| | | | - Leslie M. Shaw
- Department of Pathology and Laboratory Medicine HospitalUniversity of PennsylvaniaPennsylvaniaUSA
| | - Marc Suárez‐Calvet
- Barcelonaβeta Brain Research Center (BBRC)Pasqual Maragall FoundationBarcelonaSpain,Servei de NeurologiaHospital del MarUnitat de deteriorament cognitiu i transtorns del movimentBarcelonaSpain,IMIM (Hospital del Mar Medical Research Institute)BarcelonaSpain,Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES)MadridSpain
| | - Magda Tsolaki
- 1st Department of NeurologySchool of MedicineFaculty of Health of SciencesAristotle University of ThessalonikiThessalonikiGreece
| | - Hayrettin Tumani
- Department of Neurology and CSF LaboratoryUniversity of UlmUlmGermany
| | | | | | - Marcel M Verbeek
- Donders Institute for Brain, Cognition and BehaviourRadboud Alzheimer CentreDepartments of Neurology and Laboratory MedicineRadboud University Medical CenterNijmegenThe Netherlands
| | - Federico Verde
- Department of Neurology ‐ Stroke Unit and Laboratory of NeuroscienceIRCCS Istituto Auxologico ItalianoMilanItaly,Department of Pathophysiology and Transplantation“Dino Ferrari” Center, Università degli Studi di MilanoMilanItaly
| | - Lisa Vermunt
- Neurochemistry LabDepartment of Clinical ChemistryAmsterdam NeuroscienceAmsterdam UMCVrije Universiteit AmsterdamAmsterdamNetherlands
| | - Jonathan Vogelgsang
- Department of Psychiatry and PsychotherapyUniversity Medical Center Goettingen (UMGGoettingenGermany,McLean HospitalTranslational Neuroscience LaboratoryHarvard Medical SchoolBelmontMassachusettsUSA
| | - Jens Wiltfang
- Department of Psychiatry and PsychotherapyUniversity Medical Center Goettingen (UMGGoettingenGermany,German Center for Neurodegenerative Diseases (DZNE)GoettingenGermany,Neurosciences and Signaling GroupInstitute of Biomedicine (iBiMED)Department of Medical SciencesUniversity of AveiroAveiroPortugal
| | - Henrik Zetterberg
- Institute of Neuroscience and PhysiologyThe Sahlgrenska Academy at the University of GothenburgGothenburgSweden,Clinical Neurochemistry LaboratorySahlgrenska University HospitalMölndalSweden,UK Dementia Research Institute at UCLLondonUK,Department of Neurodegenerative DiseaseUCL Institute of NeurologyLondonUK
| | - Sylvain Lehmann
- LBPC‐PPCUniv MontpellierCHU MontpellierINSERMMontpellierFrance
| |
Collapse
|
|
2
|
Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot‐Corbel E, Bjerke M, Blanc M, Boada M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dumurgier J, Dufour‐Rainfray D, Engelborgs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau‐Rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Koertvelyessy P, Kulczynska‐Przybik A, Laplanche J, Lewczuk P, Li Q, Lleó A, Malaplate C, Marquié M, Masters CL, Mroszko B, Nogueira L, Orellana A, Otto M, Oudart J, Paquet C, Paoletti FP, Parnetti L, Perret‐Liaudet A, Poec’h K, Poesen K, Puig‐Pijoan A, Quadrio I, Quillard‐Muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suarez‐Calvet M, Tsolaki M, Tumani H, Udeh‐Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimers Dement 2021. [DOI: 10.1002/alz.057528] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
|
3
|
Faraut E, Formaglio M, Gabelle A, Grangeon L, Magnin E, Martinaud O, Boutoleau‐Bretonnière C, Cognat E, Quillard‐Muraine M, Maltête D, Wallon D. Contribution of cerebrospinal fluid Alzheimer biomarkers to the diagnosis of Creutzfeldt‐Jakob disease. Alzheimers Dement 2021. [DOI: 10.1002/alz.053545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Elise Faraut
- Neurology, Rouen University Hospital Rouen France
| | | | - Audrey Gabelle
- Memory Resource and Research Center of Montpellier, CHU de Montpellier, Hôpital Gui de Chauliac Montpellier France
| | - Lou Grangeon
- Neurology, Rouen University Hospital Rouen France
| | - Eloi Magnin
- CMRR, Neurology, CHRU Besançon, Neurosciences intégratives et cliniques EA481, Univ. Bourgogne Franche‐Comté, Besançon France
| | | | | | - Emmanuel Cognat
- Cognitive Neurology Center, GH Saint‐Louis‐Lariboisière‐Fernand‐Widal, APHP Paris France
| | | | | | - David Wallon
- CNR‐MAJ & Neurology, Rouen University Hospital Rouen France
| |
Collapse
|
|
4
|
Delaby C, Teunissen CE, Alcolea D, Amar EB, Beaume A, Bedel A, Bigot‐Corbel E, Bjerke M, Blanc M, Bousiges O, Chapman MD, DeMarco ML, D'Onofrio M, Dufour‐Rainfray D, Engelborghs S, Esselmann H, Fogli A, Galloni E, Gondolf C, Grandhomme F, Grau‐Rivera O, Hart M, Jeromin A, Keshavan A, Khalil M, Koertvelyessy P, Kulczynska‐Przybik A, Laplanche J, Lleó A, Malaplate C, Mroszko B, Nogueira L, Orellana A, Otto M, Oudart J, Paquet C, Parnetti L, Perret‐Liaudet A, Poec K, Poesen K, Puig‐Pijoan A, Quadrio I, Quillard‐Muraine M, Rucheton B, Schraen S, Suárez‐Calvet M, Tsolaki M, Tumani H, Udeh‐Momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.047209] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Constance Delaby
- IRMB, Univ Montpellier, INSERM, CHU Montpellier, (LBPC‐PPC) Montpellier France
| | - Charlotte E Teunissen
- Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience, Amsterdam UMC Vrije Universiteit Amsterdam, Netherlands Amsterdam Netherlands
| | - Daniel Alcolea
- Hospital de la Santa Creu i Sant Pau ‐ Biomedical Research Institute Sant Pau ‐ Universitat Autònoma de Barcelona Barcelona Spain
| | | | | | | | | | - Maria Bjerke
- Vrije Universiteit Brussel, UZ Brussel, UAntwerp Brussel Belgium
| | | | - Olivier Bousiges
- Hôpitaux Universitaire de Strasbourg Laboratoire de Biochimie et Biologie Moléculaire, et CNRS Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA) Strasbourg France
| | - Miles D Chapman
- Department of Neuroimmunology National Hospital for Neurology and Neurosurgery, Queen Square London United Kingdom
| | - Mari L DeMarco
- St. Paul's Hospital Providence Health Care Vancouver BC Canada
| | | | | | | | | | - Anne Fogli
- CHU Clermont‐Ferrand Clermont‐Ferrand France
| | | | | | | | | | - Melanie Hart
- Neuroimmunology & CSF Laboratory 9th floor UCL Queen Square Institute of Neurology Queen Square London London United Kingdom
| | | | | | | | - Peter Koertvelyessy
- German Center for Neurodegenerative Diseases, Magdeburg Germany Dept. of Neurology Charité Universitätsmedizin Berlin, Germany Magdeburg Germany
| | | | | | - Alberto Lleó
- Hospital de la Santa Creu i Sant Pau ‐ Biomedical Research Institute Sant Pau ‐ Universitat Autònoma de Barcelona Barcelona Spain
| | | | - Barbara Mroszko
- Department of Neurodegeneration Diagnostics Department of Biochemical Diagnostics Medical University of Białystok Bialystok Poland
| | - Léonor Nogueira
- Laboratoire de Biologie Cellulaire et Cytologie CHU‐PURPAN Toulouse France
| | - Adelina Orellana
- Research Center and Memory Clinic. Fundació ACE Institut Català de Neurociències Aplicades Barcelona Spain
| | | | | | | | - Lucilla Parnetti
- Lab of Clinical Neurochemistry University of Perugia Perugia Italy
| | - Armand Perret‐Liaudet
- Lyon University Hospital Lyon Neuroscience Research Center BIORAN Team ‐ CNRS UMR 5292 INSERM U1028, Université de Lyon Lyon France
| | | | - Koen Poesen
- Laboratory for Molecular Neurobiomarker Research (LaMoN) Department of Neurosciences Leuven Brain Institute, KU Leuven Leuven Belgium
| | | | - Isabelle Quadrio
- Lyon University Hospital Lyon Neuroscience Research Center BIORAN Team ‐ CNRS UMR 5292 INSERM U1028, Université de Lyon Lyon France
| | - Muriel Quillard‐Muraine
- Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital Department of Biology Rouen France Rouen F 76000 France
| | | | - Susanna Schraen
- Inserm, UMR 837, Alzheimer & Tauopathies Faculté de Médecine lILLE France
| | | | - Magda Tsolaki
- Aristotle University of Thessaloniki Thessaloniki Greece
| | | | | | | | - Marcel M Verbeek
- Radboud University Medical Center Donders Institute for Brain Cognition and Behaviour Radboud Alzheimer Centre Nijmegen Netherlands
| | - Federico Verde
- Stroke Unit and Laboratory of Neuroscience IRCCS Istituto Auxologico Italiano Università degli Studi di Milano, Milan Milan Italy
| | - Lisa Vermunt
- Amsterdam UMC VU University Amsterdam Netherlands
| | | | - Jens Wiltfang
- University Medical Center Goettingen (UMG) Goettingen Germany
| | - Henrik Zetterberg
- Institute of Neuroscience and Physiology The Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden
| | - Sylvain Lehmann
- IRMB, Univ Montpellier, INSERM, CHU Montpellier, (LBPC‐PPC) Montpellier France
| |
Collapse
|
|
5
|
Wallon D, Bonnevalle A, Rovelet‐Lecrux A, Lagarde J, Sarazin M, Bottlaender M, Sellal F, Jonveaux T, Heitz C, Magnin E, Ber IL, Epelbaum S, Quillard‐Muraine M, Chastan M, Hannequin D, Boluda S, Rousseau S, Richard A, Quenez O, Charbonnier C, Duyckaerts C, Campion D, Nicolas G. Phenotypes associated with MAPT duplications. Alzheimers Dement 2020. [DOI: 10.1002/alz.042008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- David Wallon
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Neurology and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Antoine Bonnevalle
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Neurology and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Anne Rovelet‐Lecrux
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Julien Lagarde
- Neurology of Memory and Language Université Paris Descartes Sorbonne Paris Cité, Centre Hospitalier Sainte Anne Paris France
- Université Paris‐Saclay CEA, CNRS, Inserm, BioMaps Orsay France
| | - Marie Sarazin
- Neurology of Memory and Language Université Paris Descartes Sorbonne Paris Cité, Centre Hospitalier Sainte Anne Paris France
- Université Paris‐Saclay CEA, CNRS, Inserm, BioMaps Orsay France
| | | | - François Sellal
- Neurology Hôpitaux Civils de Colmar & INSERM U‐1118, Faculté de Médecine, Université de Strasbourg F‐67000, Strasbourg, France Colmar France
| | - Therese Jonveaux
- CMRR Lorraine CHRU Nancy, F 54 500 Vandoeuvre les Nancy, France, Vandoeuvre Les Nancy France
| | | | - Eloi Magnin
- CMRR Neurology, CHRU Besançon, Neurosciences Intégratives et Cliniques EA481, Universite Bourgogne Franche‐Comté Besançon France
| | - Isabelle Le Ber
- University Hospitals Pitié Salpêtrière‐Charles Foix Paris France
- Institut du Cerveau et de la Moelle épinière ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University Paris France
| | - Stéphane Epelbaum
- Institut du Cerveau et de la Moelle épinière ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University Paris France
- Sorbonne Université AP‐HP, GRC n° 21, Alzheimer Precision Medicine (APM), Hôpital de la Pitié‐Salpêtrière Paris France
| | - Muriel Quillard‐Muraine
- Normandie Univ UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Biology, F 76000, Rouen France Rouen France
| | - Mathieu Chastan
- Medecine Nuclear Department Centre Henri Becquerel Rouen France
| | - Didier Hannequin
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Neurology and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Susana Boluda
- Neuropathology Laboratory Raymond Escourolle Assistance Publique des Hôpitaux de Paris Paris France
| | - Stéphane Rousseau
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Anne‐Claire Richard
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Olivier Quenez
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Camille Charbonnier
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Charles Duyckaerts
- Neuropathology Laboratory Raymond Escourolle Assistance Publique des Hôpitaux de Paris Paris France
| | - Dominique Campion
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| | - Gaël Nicolas
- Normandie University, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and CNR‐MAJ, F 76000, Normandy Center for Genomic and Personalized Medicine Rouen France
| |
Collapse
|